Understanding Considerations Impacting JAK Inhibitor Selection for Atopic Dermatitis Atopic dermatitis (AD) affects millions globally, with moderate to severe cases leading to significant treatment challenges. Recent…
The Role of Topical JAK Inhibitors in Dermatology: Exploring Their Potential Topical Janus kinase (JAK) inhibitors like Opzelura (ruxolitinib) have recently gained traction in dermatology, particularly…
